These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29850829)

  • 21. The serum level of soluble CD26/dipeptidyl peptidase 4 increases in response to acute hyperglycemia after an oral glucose load in healthy subjects: association with high-molecular weight adiponectin and hepatic enzymes.
    Aso Y; Terasawa T; Kato K; Jojima T; Suzuki K; Iijima T; Kawagoe Y; Mikami S; Kubota Y; Inukai T; Kasai K
    Transl Res; 2013 Nov; 162(5):309-16. PubMed ID: 23994650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1.
    Green BD; Irwin N; Duffy NA; Gault VA; O'harte FP; Flatt PR
    Eur J Pharmacol; 2006 Oct; 547(1-3):192-9. PubMed ID: 16945366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus.
    Cuthbertson J; Patterson S; O'Harte FP; Bell PM
    Metabolism; 2011 Jan; 60(1):52-6. PubMed ID: 20152998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased dipeptidyl peptidase-IV activity and glucagon-like peptide-1(7-36)amide degradation in type 2 diabetic subjects.
    McKillop AM; Duffy NA; Lindsay JR; O'Harte FP; Bell PM; Flatt PR
    Diabetes Res Clin Pract; 2008 Jan; 79(1):79-85. PubMed ID: 17904681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. (2S,4S)-4-Fluoro-1-{[(2-hydroxy-1,1-dimethylethyl)amino]acetyl}-pyrrolidine-2-carbonitrile monobenzenesulfonate (TS-021) is a selective and reversible dipeptidyl peptidase IV inhibitor.
    Tajima A; Yamamoto K; Kozakai A; Okumura-Kitajima L; Mita Y; Kitano K; Jingu S; Nakaike S
    Eur J Pharmacol; 2011 Mar; 655(1-3):99-107. PubMed ID: 21262219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lower dipeptidyl peptidase-4 following exercise training plus weight loss is related to increased insulin sensitivity in adults with metabolic syndrome.
    Malin SK; Huang H; Mulya A; Kashyap SR; Kirwan JP
    Peptides; 2013 Sep; 47():142-7. PubMed ID: 23872069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Higher fasting plasma concentrations of glucagon-like peptide 1 are associated with higher resting energy expenditure and fat oxidation rates in humans.
    Pannacciulli N; Bunt JC; Koska J; Bogardus C; Krakoff J
    Am J Clin Nutr; 2006 Sep; 84(3):556-60. PubMed ID: 16960169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fasting Plasma GLP-1 Is Associated With Overweight/Obesity and Cardiometabolic Risk Factors in Children and Adolescents.
    Stinson SE; Jonsson AE; Lund MAV; Frithioff-Bøjsøe C; Aas Holm L; Pedersen O; Ängquist L; Sørensen TIA; Holst JJ; Christiansen M; Holm JC; Hartmann B; Hansen T
    J Clin Endocrinol Metab; 2021 May; 106(6):1718-1727. PubMed ID: 33596309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adipose Insulin Resistance in Obese Adolescents Across the Spectrum of Glucose Tolerance.
    Hershkop K; Besor O; Santoro N; Pierpont B; Caprio S; Weiss R
    J Clin Endocrinol Metab; 2016 Jun; 101(6):2423-31. PubMed ID: 27054297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice.
    Lee EY; Kim YW; Oh H; Choi CS; Ahn JH; Lee BW; Kang ES; Cha BS; Lee HC
    Metabolism; 2014 Jun; 63(6):793-9. PubMed ID: 24684824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men.
    Matikainen N; Björnson E; Söderlund S; Borén C; Eliasson B; Pietiläinen KH; Bogl LH; Hakkarainen A; Lundbom N; Rivellese A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR
    PLoS One; 2016; 11(1):e0145890. PubMed ID: 26752550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dipeptidyl-peptidase 4 and attractin expression is increased in circulating blood monocytes of obese human subjects.
    Laudes M; Oberhauser F; Schulte DM; Schilbach K; Freude S; Bilkovski R; Schulz O; Faust M; Krone W
    Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):473-7. PubMed ID: 20198559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between GLP-1 levels and dipeptidyl peptidase-4 activity in different glucose tolerance conditions.
    Pala L; Ciani S; Dicembrini I; Bardini G; Cresci B; Pezzatini A; Giannini S; Mannucci E; Rotella CM
    Diabet Med; 2010 Jun; 27(6):691-5. PubMed ID: 20546289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fasting glucagon-like peptide-1 and its relation to insulin in obese children before and after weight loss.
    Reinehr T; de Sousa G; Roth CL
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):608-12. PubMed ID: 17460495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DXA-measured visceral fat mass and lean body mass reflect abnormal metabolic phenotypes among some obese and nonobese Chinese children and adolescents.
    Ding WQ; Liu JT; Shang YX; Gao B; Zhao XY; Zhao HP; Wu WJ
    Nutr Metab Cardiovasc Dis; 2018 Jun; 28(6):618-628. PubMed ID: 29699814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide YY is secreted after oral glucose administration in a gender-specific manner.
    Kim BJ; Carlson OD; Jang HJ; Elahi D; Berry C; Egan JM
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6665-71. PubMed ID: 16174724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between anagliptin concentration showing over 80% inhibition of plasma dipeptidyl peptidase-4 activity and its protective effect against glucagon-like peptide-1 degradation.
    Furuta S; Goto M; Tamura M; Yamashita S; Nakaya K; Furuta Y
    Drug Res (Stuttg); 2014 Mar; 64(3):130-5. PubMed ID: 23965798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic Fat Is Associated With Metabolic Syndrome and Visceral Fat but Not Beta-Cell Function or Body Mass Index in Pediatric Obesity.
    Staaf J; Labmayr V; Paulmichl K; Manell H; Cen J; Ciba I; Dahlbom M; Roomp K; Anderwald CH; Meissnitzer M; Schneider R; Forslund A; Widhalm K; Bergquist J; Ahlström H; Bergsten P; Weghuber D; Kullberg J
    Pancreas; 2017 Mar; 46(3):358-365. PubMed ID: 27941426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma soluble tumour necrosis factor-alpha receptor 2 is elevated in obesity: specific contribution of visceral adiposity.
    Cartier A; Côté M; Bergeron J; Alméras N; Tremblay A; Lemieux I; Després JP
    Clin Endocrinol (Oxf); 2010 Mar; 72(3):349-57. PubMed ID: 19650780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma DPP4 Activities Are Associated With Osteoporosis in Postmenopausal Women With Normal Glucose Tolerance.
    Zheng T; Yang L; Liu Y; Liu H; Yu J; Zhang X; Qin S
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3862-70. PubMed ID: 26259132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.